Paige is the builder of computational pathology products created to help patients and doctors perform more informed medical diagnostics. This company was founded by Thomas Fuchs, David Klimstra, Norman Selby and Peter Schüffler in 2017 and is headquartered in New York, NY. also helps life sciences companies evaluate and design personalized treatments for patients thanks to their use of machine learning and technology.

Register for Details

For more details on financing and valuation for Paige, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Who are Paige's major investors?

Casdin Capital
Goldman Sachs
Breyer Capital

Paige Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/2/2023 Series C-1 $19.5MM raised $XXX.XX $XXX.XX
3/10/2021 Series C $125.36MM raised $XXX.XX $XXX.XX
7/13/2020 Series B $71.04MM raised $XXX.XX $XXX.XX
4/23/2020 Series A-1 $6MM raised $XXX.XX $XXX.XX
2/5/2018 Series A $25.4MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Paige

Forge green plus iconForge green minus icon

What is Paige funding to date?

Paige has raised $247.3MM to date.
Forge green plus iconForge green minus icon

When was Paige founded?

Paige was founded in 2017.
Updated on: Jun 12, 2022